Skip to main content

Table 3 Comparison of the hepatic biomarkers between groups at the baseline and end of the study1

From: Evaluation of the recovery after heart surgery following preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, l-arginine, and l-glutamine: a double-blind randomized placebo-controlled clinical trial

Variable2

Gln/Arg/HMB (n = 30)

Placebo (n = 30)

P3

P-adjusted 14

AST (IU/L)

 Baseline

22.16 ± 4.86

20.53 ± 5.00

0.209

0.246

 End of the study

40.00 ± 14.65

27.83 ± 13.54

0.002

0.008

 Changes

17.83 ± 12.45

7.30 ± 13.62

0.003

0.011

P5

<0.001

0.006

  

ALT (IU/L)

 Baseline

20.0 (8.0)

21.0 (9.25)

0.450*

0.960¥

 End of the study

16.0 (13.0)

19.50 (20.50)

0.278*

0.070¥

 Changes

0.0 (12.5)

-1.50 (20.50)

0.462*

0.145¥

P5

0.123*

0.802*

  

Total bilirubin (mg/dL)

 Baseline

1.20 (1.275)

0.50 (0.50)

<0.001*

<0.001¥

 End of the study

0.80 (0.55)

1.00 (0.50)

0.198*

0.061¥

 Changes

−0.40 (0.92)

0.42 (0.60)

<0.001*

<0.001¥

P5

0.002*

0.001*

  

Direct bilirubin (mg/dL)

 Baseline

0.50 (0.10)

0.50 (0.12)

0.065*

0.024¥

 End of the study

0.50 (0.20)

0.40 (0.22)

0.004*

0.165¥

 Changes

0.0 (0.30)

0.0 (0.31)

0.451*

0.965¥

P5

0.301*

0.075*

  

Indirect bilirubin (mg/dL)

 Baseline

0.70 (0.50)

0.50 (0.22)

0.003*

0.001¥

 End of the study

0.60 (0.60)

0.65 (0.50)

0.964*

0.257¥

 Changes

−0.10 (0.40)

0.20 (0.50)

0.008*

0.012¥

P5

0.214*

0.007*

  
  1. 1CPK creatine phosphokinase, CPK-MB creatine phosphokinase myocardial band, AST aspartate aminotransferase, ALT alanine aminotransferase
  2. 2Data are presented as mean ± SD for normally distributed continuous variables or as median (IQR) for non-normally distributed continuous variables
  3. 3Calculated using the independent sample t-test (variables that entered as logarithm form are indicated by “**”) or Mann-Whitney U-test (indicated by “*”)
  4. 4Calculated using ANCOVA (variables that entered as logarithm form are indicated by “**”) or non-parametric ranked ANCOVA using generalized estimation equation (indicated by “¥”), adjusted for the effect of BMI, age, gender, and history of HTN
  5. 5Calculated using the paired t-test or Wilcoxon rank test (indicated by “*”)